Escolar Documentos
Profissional Documentos
Cultura Documentos
doi: 10.1111/1440-1681.12164
SUMMARY
1. We found a group of non-platelet RNA-containing particles (NPRCPs) in human umbilical cord blood. These particles can aggregate, fuse and become non-nucleated cells when
cocultured with nucleated cells in vitro. The non-nucleated
cells further differentiate into nucleated cells expressing octamer binding transcription factor 4 (OCT4). The NPRCPs
are approximately 15 lm in diameter, have a thin bilayer
membrane, contain short RNAs and microRNAs and express
OCT4, sex-determining region Y 2 (SOX2) and DEAD box
polypeptide 4 (DDX4). To conrm the function of NPRCPs in
vivo, we examined the effects of tail vein-injected green uorescent protein (GFP)-labelled NPRCPs on mouse kidneys
damaged by prior ischaemia and reperfusion from Day 1 to
Week 6.
2. Within 1 day of injection of NPRCPs, immunouorescence and immunohistochemistry revealed a large number of
extravasated NPRCPs in the renal calyces, damaged glomeruli and duct tubules. During the course of regeneration,
NPRCPs fused into large, non-nucleated cellular structures
that further became large nucleated cells to regenerate multicellular kidney tubules. In addition, many NPRCPs became
tiny nucleated cellular structures that further differentiated
into interstitial cells in connective tissue. The extravasated
NPRCPs also arranged themselves into non-cell glomerular
structures before further regenerating into nucleated cells of
the glomerulus.
3. In conclusion, the results demonstrate that, via different
patterns of differentiation, NPRCP-derived cells can regenerate mouse kidney tissue damaged by ischaemia.
Key words: acute ischaemia, DEAD box polypeptide 4,
glomerulus, kidney tubules, non-platelet RNA-containing
particles, octamer binding transcription factor 4, sexdetermining region Y 2 , stem cells.
INTRODUCTION
After more than a decade of studies, two unresolved questions
about adult stem cells continue to be debated: (i) whether stem
cells can self-renew; and (ii) what type or types of adult stem
cells possess multilineage regenerative capacity. With regard to
Correspondence: Wuyi Kong, Haidian District, Shangdi E. Street 51,
Jing-Meng A101 Beijing, China. Email: wuyikong@yahoo.com
Received 1 February 2013; revision 30 July 2013; accepted 14 August
2013.
2013 Wiley Publishing Asia Pty Ltd
METHODS
Animals and materials
BALB/c and green uorescent protein (GFP)-transgenic
(FVB.Cg-Tg(ACTB-EGFP)B5Nagy/J) mice (Jackson Laboratory,
Bar Harbor, ME, USA) were bred and maintained in Beijing University. Mice received food and water ad libitum. All animal procedures followed the guidelines of the Animal Regulatory
Department of Beijing University. The OCT4, SOX2, DDX4,
E-cadherin and b1-integrin antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against b-actin
and tubulin were from CWBiotech (Beijing, China). Alexa Fluor
goat anti-rabbit IgG was from Invitrogen (Carlsbad, CA, USA).
Other chemicals were from Sigma Chemical (Shanghai, China).
Isolation and culture of NPRCPs
Blood was collected from 6 to 8-week-old GFP-transgenic mice
by cardiac puncture. The NPRCPs were isolated from the blood
by centrifugation at 200 g for 10 min at 20C, followed by
centrifugation at 5000 g for 10 min at 20C. The pellet was
resuspended in culture medium (a-minimum essential medium
(MEM) containing 20% fetal bovine serum and antibiotics) on
collagen-coated plates in a 5% CO2 humid incubator at 37C.
The medium was changed every other day. Particles were cultured for >2 weeks before collection for transplantation studies.
Because the lifespan of platelets is <10 days, most contaminating
platelets were removed or were no longer functioning after
2 weeks culture. The cultured NPRCPs were detached by gently
scraping the culture plates with a cell lifter in phosphate-buffered
saline (PBS) containing 0.5 mm EDTA. Detached NPRCPs were
placed in a centrifuge tube and the number of particles determined using a platelet-counting method.27 Briey, 50 lL wellmixed NPRCPs was diluted in 1 mL of 1% ammonium oxalate
in distilled water. The solution was then added to the chamber of
a haemocytometer by capillary action. The haemocytometer was
placed inside a Petri dish for 1020 min to allow the NPRCPs to
725
W Kong et al.
726
conventional uorescence microscopy. Control tissues were treated with non-specic antiserum from the same species of primary
antibody. Staining was visualized by standard uorescence
microscopy (Leica, Wetzlar, Germany).
RESULTS
Morphology and expression of mouse NPRCPs
Non-platelet RNA-containing particles were isolated from GFPtransgenic mice. Two days after seeding, low- and high-magnication microscopy revealed that most populations were small
vesicles of 15 lm in diameter (Fig. 1a,e). These vesicles were
actively moving on the culture plates. Two weeks later, the cultured vesicles were less active. Furthermore, their vesicle structure was replaced by a particle-like structure (Fig. 1b,f). This
morphological change suggests that the NPRCPs may be coated
with serum proteins or that they had absorbed serum proteins
during culture. Non-platelet RNA-containing particles were used
for in vivo transplantation after 2 weeks culture to ensure that the
regenerative function was not via platelets or platelet-released
(k)
(b)
(a)
(l)
(c)
(d)
(m)
(e)
(f)
(g)
(n)
(h)
(i)
(j)
(o)
Fig. 1 Morphology and expression of mouse non-platelet RNA-containing particles (NPRCPs), by inverted microscopy, after (a) 2 days and (b) 2 weeks
culture. The NPRCPs were cultured on cover slides for 20 days and were xed and stained with (c) haematoxylin and eosin (H&E) and (d) green uorescent protein (GFP). (eg) High-magnication microscopy of NPRCPs after (e) 2 days and (f) 2 weeks culture and (g) H&E staining. (hj) Electron
microscope images show different morphologies with a dense nuclear structure inside the vesicles. The NPRCPs from GFP-transgenic mice were cultured
for 3 weeks. Immunouorescence staining revealed coexpression of (k) octamer binding transcription factor 4 (OCT4), (l) DEAD box polypeptide 4
(DDX4), (m) sex-determining region Y 2 (SOX2), (n) b-actin and (o) tubulin. Green uorescent protein is expressed on the surface and in the centre of
NPRCPs; OCT4, DDX4, SOX2 are expressed in the centre of NPRCPs and b-actin and tubulin are expressed mainly on the surface of NPRCPs. DAPI,
4,6-diamidino-2-phenylindole. Bars, 20 lm (ad); 10 lm (eg); 500 nm (hj); 10 lm (ko).
(a)
727
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)
W Kong et al.
728
Regenerative patterns determined on Day 1 after NPRCP
injection
(b)
(d)
(e)
729
(c)
(f)
(g)
(h)
(i)
(j)
Fig. 3 Non-platelet RNA-containing particles (NPRCPs) migrate to damaged kidneys. (ae) One day after injection of NPRCPs in mice with ischaemiadamaged kidneys, NPRCPs were found (a) as small groups of aggregates in a glomerulus (dashed line), (b) large aggregations in the tubule area or (c,d)
lined up in the interstitial areas in the kidneys (c) or in the large tubule (d), as well as (e) in a blood vessel in the renal capsule. (f) Haematoxylin and
eosin (H&E)-stained and (g) green uorescent protein (GFP)-positive tiny nucleated particles were found in connective tissues. (hj) Aggregated NPRCPs
coexpressed (h) DEAD box polypeptide 4 (DDX4), (i) octamer binding transcription factor 4 (OCT4) and (j) sex-determining region Y 2 (SOX2). Tiny
4,6-diamidino-2-phenylindole (DAPI)-positive particles were detected (j). Bars, 20 lm (ad); 10 lm (ej).
W Kong et al.
730
(a)
(b)
(c)
(d)
(f)
(e)
(g)
Fig. 5 Interstitial tissue regeneration. Tiny cells coexpressed green uorescent protein (GFP; arrows) and DEAD box polypeptide 4 (DDX4) in
interstitial areas 1 week after injection of non-platelet RNA-containing
particles (NPRCPs) into mice with ischaemia-damaged kidneys. Highmagnication microscopy of 4,6-diamidino-2-phenylindole (DAPI; boxed
area) and haematoxylin and eosin (H&E) staining revealed tiny nuclei in
GFP-positive cells (arrows). Bars, 20 lm (merge); 10 lm (H&E).
(h)
Fig. 4 Renal tubule regeneration. Green uorescent protein (GFP)-positive non-platelet RNA-containing particles (NPRCPs) fuse into large
patch-like structures (a) 1 and (b) 2 weeks after injection into mice with
ischaemia-damaged kidneys. (a) The fused patches also coexpress sexdetermining region Y 2 (SOX2; red). (c,d) Haematoxylin and eosin
(H&E) staining revealed large cellular structures containing central weak
staining for nuclear materials (arrows). (e,f) Green uorescent protein uorescence further conrmed that these large cellular structures were
formed by the fusion of NPRCPs (arrows). (g) The GFP-positive large
tubules coexpressed octamer binding transcription factor 4 (OCT4). No
nuclei were detected by (g) 4,6-diamidino-2-phenylindole (DAPI) or (h)
H&E staining. Bars, 100 lm (a); 50 lm (b); 10 lm (ce); 20 lm (fh).
structures (Fig. 7j) that were also GFP positive (Fig. 7k). These
data suggest that NPRCPs fused to form new large cells that
further regenerated renal tubules.
DISCUSSION
In the present study we report the presence of NPRCPs in mouse
blood. Similar to NPRCPs in human umbilical cord blood, mouse
NPRCPs express OCT4, SOX2 and DDX4, which has not been
described in the case of MSC-released exosomes. We found that
a large number of injected NPRCPs migrated to ischaemiadamaged kidneys, where they aggregated, fused and became
nucleated stem cells to regenerate the damaged tissues. The
mechanism underlying regeneration by NPRCPs in vivo was
similar to that described in vitro, namely via a self-assembly
mechanism. We also found that most stem cells participating in
the regeneration were derived by self-assembly, which may be
the main mechanism for the production of stem cells by NPRCPs
during tissue damage. Although the circulation contains numerous
small particles, such as exosomes, cellular membrane vesicles,
microparticles and DNA fragments, NPRCPs may not belong to
any of these particle types. The NPRCPs are released from
OCT4-expressing cells,2 possibly via ssion, and are 10-fold
larger than MSC-released exosomes described by others.23
731
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
Fig. 6 Glomerulus regeneration. (a) One week after injection of non-platelet RNA-containing particles (NPRCPs) into mice with ischaemia-damaged
kidneys. Green uorescent protein (GFP) and DEAD box polypeptide 4 (DDX4) are coexpressed as small particles in a non-nuclear area (dashed lines).
(b) Two weeks after transplantation. The GFP-positive glomerulus coexpressed octamer binding transcription factor 4 (OCT4). 4,6-Diamidino-2-phenylindole (DAPI) staining did not reveal any nuclei (dashed lines). (ch) Haematoxylin and eosin (H&E) staining revealed possible regenerative stages of
glomeruli from Day 1 to Week 4 after injection (tiny nuclei with arrows). Bars, 10 lm.
W Kong et al.
732
(a)
(b)
(d)
(c)
(e)
(f)
(g)
(h)
(i)
(j)
Fig. 7 Fused non-platelet RNA-containing particles (NPRCPs) become large nucleated stem cells to regenerate renal tubules. (a) Kidneys from NPRCPinjected mice were stained with haematoxylin and eosin and (b) green uorescent protein (GFP). (c,d) In the upper, unrepaired, damaged areas, plasma
forms glomerulus shapes (c, arrows) that are also GFP positive (d, arrows). (e) The materials lling the glomerulus were not erythrocytes (arrow). (f) Glomerulus structures and (g) tubule structures were positive for GFP staining (brown). (h) The GFP-expressing cellular structures also contained dot-shaped
E-cadherin expression (arrows) 1 week after injection of NPRCPs. (i) Large GFP-expressing nucleated cells (arrows) also expressed E-cadherin. (j) Haematoxylin and eosin staining revealed large cells in the tubule structures (arrows) that were also GFP positive (k, arrow). Images are representative results
for kidneys from three mice each at 1 and 2 weeks after injection of NPRCPs transplantation. Bars, 200 lm (c,d); 20 lm (ek).
ACKNOWLEDGEMENTS
This work was supported by a grant from the Department of
Technology, Inner Mongolia Government, China. The authors
thank Laura Smales (BioMedEditing) and Dr Natalie Korszniak
for English language editing.
DISCLOSURE
WK, MN and XZ are employees of Khasar Medicine at Beijing,
China. WK declares the invention of intellectual property led as
NPRCPs, PFDNCs and the use thereof.
733
REFERENCES
1. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441: 106874.
2. Kong W, Nuo M, Zhu XP, Han XJ, Luo L, Wang X. Pre-stem cell
formation by non-platelet RNA-containing particle fusion. Clin. Exp.
Pharmacol. Physiol. 2013; 40: 41221.
3. Bei SH, Cao MS, Chen CC et al. Time-lapse microcinematographic
and phase contrast studies on the cell reformation of Chirocephalus
yolk granules in vitro. Sci. Sin. B 1983; 26: 45463.
4. Shizuru JA, Negrin RS, Weissman IL. Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 2005; 56: 50938.
5. Wagers AJ, Christensen JL, Weissman IL. Cell fate determination
from stem cells. Gene Ther. 2002; 9: 60612.
6. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;
279: 152830.
7. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: Cells bearing neuronal antigens generated in
vivo from bone marrow. Science 2000; 290: 177982.
8. Lagasse E, Connors H, Al-Dhalimy M et al. Puried hematopoietic
stem cells can differentiate into hepatocytes in vivo. Nat. Med.
2000; 6: 122934.
9. Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of
atherosclerosis. Nat. Med. 2002; 8: 4039.
10. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 419.
11. DIppolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller
PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a
unique population of postnatal young and old human cells with
extensive expansion and differentiation potential. J. Cell Sci. 2004;
117: 297181.
12. Kebriaei P, Robinson S. Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease. Front. Oncol.
2011; 1: 16.
13. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil
is in the details. Cell Stem Cell 2009; 4: 20616.
14. Ankrum J, Karp JM. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol. Med. 2010; 16: 2039.
15. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells. The state of transdifferentiation and modes of
tissue repair: Current views. Stem Cells 2007; 25: 2896902.
16. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult
stem cell signaling and therapy. Circ. Res. 2008; 103: 120419.
17. Sanchez-Gonzalez DJ, Mendez-Bolaina E, Trejo-Bahena NI. Platelet-rich plasma peptides: Key for regeneration. Int. J. Pept. 2012;
2012: 532519.
18. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich
plasma. Where are we now and where are we going?. Sports Health
2010; 2: 20310.
19. Hayon Y, Dashevsky O, Shai E, Varon D, Leker RR. Platelet microparticles promote neural stem cell proliferation, survival and differentiation. J. Mol. Neurosci. 2012; 47: 65965.
20. Jiang L, Song XH, Liu P et al. Platelet-mediated mesenchymal stem
cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension. Cell Transplant. 2012; 21: 146375.
21. Hayon Y, Dashevsky O, Shai E, Brill A, Varon D, Leker RR. Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr. Neurovasc. Res. 2012; 9: 18592.
22. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs.
Nucleic Acids Res. 2010; 38: 21524.
23. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: A
novel stem cell-based therapy for cardiovascular disease. Regen.
Med. 2011; 6: 48192.
734
W Kong et al.
24. Lee C, Mitsialis SA, Aslam M et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012; 126: 260111.
25. Li T, Yan Y, Wang B et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver brosis. Stem Cells
Dev. 2013; 22: 84554.
26. Lai RC, Tan SS, Teh BJ et al. Proteolytic potential of the MSC exosome proteome: Implications for an exosome-mediated delivery of
therapeutic proteasome. Int. J. Proteomics 2012; 2012: 971907.
27. Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt
B. Structural and functional characterization of the mouse von
Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood 2000; 95: 88693.
28. Kong W, Li S, Longaker MT, Lorenz HP. Blood-derived small Dot
cells reduce scar in wound healing. Exp. Cell Res. 2008; 314: 1529
39.
29. Spees JL, Olson SD, Ylostalo J et al. Differentiation, cell fusion,
and nuclear fusion during ex vivo repair of epithelium by human
adult stem cells from bone marrow stroma. Proc. Natl Acad. Sci.
USA 2003; 100: 2397402.
30. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of
bone-marrow-derived cells with Purkinje neurons, cardiomyocytes
and hepatocytes. Nature 2003; 425: 96873.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Figure S1. Non-platelet RNA-containing particles (NPRCPs) are possibly covered and carried by the circulating plasma. Haematoxylin
and eosin staining shows numerous small dot-shaped particles in the kidney ischaemia-damaged area. Some were covered by plasma
(red) and some initiated cellularization to become larger circled haematoxylin-positive structures (arrows). Bar, 20 lm.
Figure S2. Individual images for the merged images shown in Fig. 4f,g. Aggregated non-platelet RNA-containing particles (NPRCPs)
coexpress DEAD box polypeptide 4 (DDX4), octamer binding transcription factor 4 (OCT4) and sex-determining region Y 2 (SOX2).
Bars, 10 lm.
Figure S3. Kidney regeneration during the 4 weeks after non-platelet RNA-containing particle (NPRCP) transplantation. Ischaemiadamaged kidneys were stained with haematoxylin and eosin. Kidneys 1 day and 1 week after ischaemia exhibit necrotic areas covering
more than two-thirds of the kidney. Two weeks after ischaemic, the necrotic area has decrease to approximately of the kidney. After
3 weeks, the ischaemia-damaged kidney has regenerated the cortex but not the medulla. After 4 weeks, most of the ischaemia-damaged
kidney has been regenerated.